newsfilter
← Latest News
GlobeNewswire·

Aeterna Zentaris Abstract Accepted for Presentation at 13th International Congress on Autoimmunity

– Company to present regarding AIM Biologicals as a potential therapeutic treatment option for neuromyelitis optica spectrum disorder ("NMOSD"), an orphan indication with strong unmet medical need TORONTO, ONTARIO, April 11, 2022 (GLOBE NEWSWIRE